Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.96−0.01 (-0.51%)
Close on Nov 13, 2026Market cap $609.23MP/E –Yield 0.00%
Pacific Biosciences of California statistics
85 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 11, 2027 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 2.54
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- -0.55%
- 3.32%
- Shares Change (QoQ)
- 0.46%
- 0.20%
- Float
- 297M
- 37M
- Shares Held by Insiders
- 4.33%
- 10.5%
- Shares Held by Institutions
- 61.5%
- 60.5%
Short sellingIndustry
- Short Interest
- 54M
- –
- Short Interest Change
- 14.4%
- -2.57%
- Short % of Float
- 18.1%
- 5.11%
- Short % of Shares Outstanding
- 17.3%
- 3.98%
- Days to Cover
- 4.14
- 3.94
Stock price statisticsIndustry
- 52-Week High
- $3.44
- –
- 52-Week Low
- $1.07
- –
- 20-Day Moving Average
- $2.29
- –
- 50-Day Moving Average
- $2.00
- –
- 200-Day Moving Average
- $1.60
- –
- Average True Range (14)
- $0.28
- –
- Price Change (1 Week)
- -13.1%
- 0.99%
- Price Change (1 Month)
- 0.00%
- -3.52%
- Price Change (3 Months)
- 62.0%
- -7.86%
- Price Change (6 Months)
- 75.0%
- -1.12%
- Price Change (YTD)
- 4.81%
- -2.92%
- Price Change (1 Year)
- 12.6%
- -1.37%
- Price Change (3 Years)
- -72.9%
- 3.24%
- Price Change (5 Years)
- -92.8%
- -50.4%
- Price Change (10 Years)
- -76.3%
- 58.9%
- Average Volume (10 Days)
- 12M
- –
- Average Volume (20 Days)
- 12M
- –
- Average Volume (90 Days)
- 11M
- –
- Relative Volume
- 0.64
- 0.76
- Relative Strength Index (14)
- 43.1
- 46.7
- Volatility (1 Year)
- 93.6%
- 64.2%
- Beta (5 Years)
- 2.18
- 1.04
MarginsIndustry
- Pretax Margin
- -80.9%
- -2.32%
- EBITDA Margin
- -81.3%
- -2.52%
- FCF Margin
- -88.8%
- 0.65%
Returns on capitalIndustry
- Return on Assets (ROA)
- -17.2%
- -12.3%
- Return on Capital Employed (ROCE)
- -20.0%
- -8.13%
Financial positionIndustry
- Current Ratio
- 4.62
- 2.49
- Quick Ratio
- 3.57
- 1.53
- Interest Coverage
- -17.15
- -1.63
GrowthIndustry
- Revenue Growth (YoY)
- 4.41%
- 9.42%
- Revenue Growth (3Y CAGR)
- 7.64%
- 7.08%
- Revenue Growth (5Y CAGR)
- 15.2%
- 11.8%
EfficiencyIndustry
- Asset Turnover
- 0.21
- 0.59
- Inventory Turnover
- 1.87
- 2.20
- Revenue Per Employee
- $332.77K
- $331.99K
- Profits Per Employee
- -$270.58K
- -$46.47K
- Employee Count
- 485
- 193
- WACC
- 16.0%
- 9.91%
Income statement (TTM)Industry
- Pretax Income
- -$130.52M
- -$1.83M
Balance sheetIndustry
- Net Cash (Debt)
- $199.42M
- $3.95M
- Net Cash Per Share
- $0.64
- $0.26
- Equity (Book Value)
- -$61.38M
- $63.80M
- Book Value Per Share
- -$0.20
- $3.26
- Tangible Book Value
- -$391.31M
- $11.61M
- Working Capital
- $241.26M
- $57.32M
Cash flow (TTM)Industry
- Capital Expenditures
- -$6.45M
- -$3.94M
- FCF Per Share
- -$0.46
- -$0.00
Dividends and yieldsIndustry
- Earnings Yield
- -21.5%
- -4.76%
- FCF Yield
- -23.5%
- 0.28%
- Dividend Yield
- 0.00%
- 0.79%
- Shareholder Yield
- 0.00%
- 1.12%
- Dividend Per Share
- $0.00
- $0.72
- Years of Dividend Growth
- 0
- 0
Taxes and interestIndustry
- Interest Expense
- $7.65M
- $5.40M
- Income Tax
- $713.00K
- $1.55M
Scores and fair valueIndustry
- Altman Z-Score
- -4.92
- 2.47
- Piotroski F-Score
- 4
- 5
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PACB | S&P 500 | Difference | PACB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -4.4% | -3.0% | −1.4 pts | ||
| 3 months | +70.4% | -2.8% | +73.2 pts | ||
| Year to date | +4.8% | +11.5% | −6.7 pts | ||
| 1 year | +20.2% | +13.5% | +6.8 pts | ||
| 3 years | -69.6% | +77.7% | −147.3 pts | -32.7% | +21.1% |
| 5 years | -92.8% | +72.6% | −165.4 pts | -41.0% | +11.5% |
| 10 years | -75.4% | +308.2% | −383.5 pts | -13.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
54M PACB shares were sold short on Oct 30, 2026, up 14.4% from the previous report, or 18.05% of the shares available to trade. At recent volumes it would take 4.1 days to buy them back. Over the last 20 sessions, 58.7% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 53,681,529 | +14.4% | 12,977,933 | 4.1 |
| Oct 15, 2026 | 46,933,159 | -0.6% | 21,423,384 | 2.2 |
| Sep 30, 2026 | 47,224,448 | -3.4% | 15,907,977 | 3.0 |
| Sep 15, 2026 | 48,892,225 | -1.4% | 4,660,230 | 10.5 |
| Aug 31, 2026 | 49,578,770 | -7.2% | 7,342,641 | 6.8 |
| Aug 14, 2026 | 53,412,027 | +9.0% | 8,056,891 | 6.6 |
| Jul 31, 2026 | 49,004,841 | +6.0% | 6,666,706 | 7.3 |
| Jul 15, 2026 | 46,237,636 | -2.6% | 4,638,329 | 10.0 |
| Jun 30, 2026 | 47,490,204 | -21.6% | 7,291,153 | 6.5 |
| Jun 15, 2026 | 60,560,138 | +24.3% | 5,954,109 | 10.2 |
| May 29, 2026 | 48,707,384 | -18.7% | 5,684,330 | 8.6 |
| May 15, 2026 | 59,926,798 | +27.3% | 6,645,578 | 9.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?